AE-M Vaccine / Generex - LARVOL DELTA

AEK08 Ultrasound Abdomen (DGU 2024) - "Basic sonography, Doppler sonography, urological emergencies and abdomen expert course (practical exercises and semi-live cases)[incl. DEGUM certificate (for recognition of DEGUM levels up to level III course instructor) and CME points]"

Urology

AES-P-023. AES08 Saturday Biotransformations: Bioremediation, Biodegradation, Biofouling and Biocorrosion (ASM Microbe 2024) - "DESCRIPTION Poster viewing hours are 10:00 am - 5:00 pm. Posters will be presented twice from 10:30 am - 11:30 am and 4 pm - 5 pm at their assigned poster board."

AES-P-022. AES08 Friday Biotransformations: Bioremediation, Biodegradation, Biofouling and Biocorrosion (ASM Microbe 2024) - "DESCRIPTION Poster viewing hours are 10:00 am - 5:00 pm. Posters will be presented twice from 10:30 am - 11:30 am and 4 pm - 5 pm at their assigned poster board."

AES-P-024. AES08 Sunday Biotransformations: Bioremediation, Biodegradation, Biofouling and Biocorrosion (ASM Microbe 2024) - "DESCRIPTION Poster viewing hours are 10:00 am - 5:00 pm. Posters will be presented twice from 10:30 am - 11:30 am and 3 pm - 4 pm at their assigned poster board."

AE08: Sports Medicine (AAOS 2024) - No abstract available

First Report of Xanthomonas campestris Causing Leaf Blight on Buttercup (Ranunculus asiaticus) in South Carolina, USA. (PubMed, Plant Dis) - "campestris type strain (AE008922)...This is the first report of X. campestris causing bacterial leaf blight in R. asiaticus in South Carolina. Since more than 50% of the flower producers/farmers grow Ranunculus in South Carolina, further work is necessary to determine how widespread the disease is and its economic impact."

Journal

P094. AES08-2 Biotransformations: Bioremediation, Biodegradation, Biofouling and Biocorrosion (ASM Microbe 2023) - "DESCRIPTION Poster viewing hours are 10:00 am - 5:00 pm. Posters will be presented twice from 10:30 am - 11:30 am and 4:00 pm – 5:00 pm at their assigned poster board."

P016. AES08-1 Biotransformations: Bioremediation, Biodegradation, Biofouling and Biocorrosion (ASM Microbe 2023) - "DESCRIPTION Poster viewing hours are 10:00 am - 5:00 pm. Posters will be presented twice from 10:30 am - 11:30 am and 4:00 pm – 5:00 pm at their assigned poster board."

P174. AES08-3 Biotransformations: Bioremediation, Biodegradation, Biofouling and Biocorrosion (ASM Microbe 2023) - "DESCRIPTION Poster viewing hours are 10:00 am - 4:00 pm. Posters will be presented twice from 10:30 am - 11:30 am and 3:00 pm – 4:00 pm at their assigned poster board."

"CUPE Welcomes New Members at Summerland Community Support https://t.co/aE08Fce9Ee" (@NewsFromBW)

Poster. AES08 - Viruses in the Environment (ASM Microbe 2022) - "Poster Viewing Hours are 10:00 am - 5:00 pm. However, posters will be presented twice during Poster Presentation 1 (10:30 am - 11:30 am) and Poster Presentation 2 (4 pm - 5 pm) at their assigned poster board."

In-depth Symposium. AES08. Metros to Monuments: Microbiomes of Built Environment Surfaces (ASM Microbe 2022) - "Discuss current technologies study microbial communities and their metabolic products associated with different built-environments.. . This session will focus on the composition, viability, and characterization of microbial communities and their metabolic products associated with different indoor and outdoor built-environments (e.g., building surfaces, monuments, textiles, etc.)."

Black rot disease incited by Indian race 1 of Xanthomonas campestris pv. campestris in Brassica juncea L. cv. Pusa Bold in India. (PubMed, Plant Dis) - "The nucleotide BLAST analysis of 16S rRNA, AvrBs1, AvrGf1 showed a 100% identity with different Xcc strains reported from Germany (B100; AM920689), Brazil (ATCC 33913; AE008922), India (Xcc-C7; CP077958), France (CFBP 5817; CM002673) and China (8004; CP000050) (Singh et al...Pusa Bold incited by Xcc race 1, India. Previous research reported the black rot disease on other species of the Brassica genus e.g., B. oleracea, and B. napus in Serbia (Popovic et al., 2013) and Argentina (Gaetan et al., 2005)."

Journal • Infectious Disease

[VIRTUAL] AESP121 - AES08 Viruses in the Environment (WMF 2021) - "Participants may also contact iPoster presenters using the networking tools within the digital platform. Information on accessing the iPoster Hall is available under General Information on the dashboard."

Study on the Identification of Samples Mistyped as O Phenotype and the Strategy of Safe Blood Transfusion (PubMed, Zhongguo Shi Yan Xue Ye Xue Za Zhi) - "The phenotypes of Ael, Bel, Aw and para-Bombay subtypes are easily misjudged as type O. Molecular technology is helpful to identify the genotype of subtypes, and the corresponding transfusion strategies could be reasonably performed."

Journal

[VIRTUAL] CS.AE.08 - Co-Pilot Meetup #8 (AHA 2020) - "Join your Co-Pilot in an informal networking setting. You'll be able to interact directly with you Co-Pilot to ask them your questions about AHA 2020."

A Trial to Establish the Feasibility of Combining Either the Tyrosine Kinase Inhibitor AC220,CXCR4 Inhibitor Plerixafor or HSP90 Inhibitor Ganetespib With Chemotherapy in Older Patients With Acute Myeloid Leukaemia and High Risk Myelodysplastic Syndrome. (clinicaltrials.gov) - P1/2; N=113; Completed; Sponsor: Cardiff University; N=90 -> 113

Enrollment change • Acute Myelogenous Leukemia • Biosimilar • Hematological Malignancies • Leukemia • Myelodysplastic Syndrome • Oncology

Combined Basal-bolus Insulin and Post-exercise Carbohydrate Feeding Strategy in T1DM (clinicaltrials.gov) - P=N/A; N=10; Active, not recruiting; Sponsor: Northumbria University

New trial • Biosimilar • Diabetes

An Exploratory Haemodynamic Study in Patients With Compensated Cirrhosis and Portal Hypertension (clinicaltrials.gov) - P2; N=50; Recruiting; Sponsor: Novartis Pharmaceuticals; Trial primary completion date: Sep 2014 ->Jan 2015

Trial primary completion date • Biosimilar • Fibrosis

A Study to Compare the Pharmacokinetics and Safety of Optivate® and Haemate P® in Patients With Von Willebrand Disease. (clinicaltrials.gov) - P2; N=N/A; Completed; Sponsor: Bio Products Laboratory; Not yet recruiting -> Completed

Trial completion • Biosimilar • Hemophilia

Simvastatin in Aneurysmal Subarachnoid Haemorrhage (STASH) a Multicentre Randomised Controlled Clinical Trial (clinicaltrials.gov) - P3; N=803; Completed; Sponsor: Cambridge University Hospitals NHS Foundation Trust; Trial primary completion date: Feb 2013 ->Sep 2013

Trial primary completion date • Biosimilar

The Application of Standards and Recommendations to Clinical Ethics Consultation in Practice: An Evaluation at German Hospitals. (PubMed) - "The executive board of the Academy for Ethics in Medicine (AEM) and two AEM working groups formulated standards and recommendations for clinical ethics consultation in 2010, 2011, and 2013...This applies particularly for activity reports in order to evaluate the activities. Internal evaluation could take place accordingly."

Journal • Biosimilar

British Randomised Controlled Trial of Atrioventricular (AV) and Interventricular (VV) Optimisation (BRAVO) (clinicaltrials.gov) - P=N/A; N=402; Active, not recruiting; Sponsor: Imperial College London; Trial primary completion date: Jun 2014 ->Jan 2015

Trial primary completion date • Acute Coronary Syndrome • Biosimilar • Heart Failure

Efficiency of TISSEEL for Sleeve Gastrectomy Complications (clinicaltrials.gov) - P3; N=600; Recruiting; Sponsor: Centre Hospitalier Universitaire, Amiens; Not yet recruiting -> Recruiting

Enrollment open • Biosimilar • Hemophilia • Immunology • Obesity • Oncology

A promising first year: Happy birthday AE&M! (PubMed) - Arch Endocrinol Metab - No abstract available.

Journal • Biosimilar